SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001387131-18-004016
Filing Date
2018-08-14
Accepted
2018-08-14 17:07:01
Documents
45
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ohrp-10q_063018.htm 10-Q 410253
2 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER ex31-1.htm EX-31.1 10866
3 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER ex31-2.htm EX-31.2 10765
4 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER ex32-1.htm EX-32.1 4909
5 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER ex32-2.htm EX-32.2 5086
  Complete submission text file 0001387131-18-004016.txt   1907661

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ohrp-20180630.xml EX-101.INS 221617
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ohrp-20180630.xsd EX-101.SCH 21240
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ohrp-20180630_cal.xml EX-101.CAL 34150
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ohrp-20180630_def.xml EX-101.DEF 99471
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ohrp-20180630_lab.xml EX-101.LAB 203100
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ohrp-20180630_pre.xml EX-101.PRE 156737
Mailing Address 800 THIRD AVENUE 11TH FLOOR NEW YORK NY 10022
Business Address 800 THIRD AVENUE 11TH FLOOR NEW YORK NY 10022 (212) 682-8452
Ohr Pharmaceutical Inc (Filer) CIK: 0001173281 (see all company filings)

IRS No.: 465622433 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-35963 | Film No.: 181018731
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1